GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nephros Inc (NAS:NEPH) » Definitions » Cyclically Adjusted FCF per Share

NEPH (Nephros) Cyclically Adjusted FCF per Share : $-0.43 (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Nephros Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Nephros's adjusted free cash flow per share for the three months ended in Dec. 2024 was $0.120. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.43 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 20.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 21.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 38.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Nephros was 56.00% per year. The lowest was 19.30% per year. And the median was 33.80% per year.

As of today (2025-05-11), Nephros's current stock price is $1.90. Nephros's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 was $-0.43. Nephros's Cyclically Adjusted Price-to-FCF of today is .


Nephros Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Nephros's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nephros Cyclically Adjusted FCF per Share Chart

Nephros Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.01 -0.86 -0.80 -0.53 -0.43

Nephros Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.53 -0.50 -0.50 -0.48 -0.43

Competitive Comparison of Nephros's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, Nephros's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nephros's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nephros's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Nephros's Cyclically Adjusted Price-to-FCF falls into.


;
;

Nephros Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nephros's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.12/133.1571*133.1571
=0.120

Current CPI (Dec. 2024) = 133.1571.

Nephros Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 -0.223 99.621 -0.298
201506 -0.154 100.684 -0.204
201509 -0.310 100.392 -0.411
201512 -0.248 99.792 -0.331
201603 -0.102 100.470 -0.135
201606 -0.053 101.688 -0.069
201609 -0.147 101.861 -0.192
201612 -0.097 101.863 -0.127
201703 -0.120 102.862 -0.155
201706 -0.084 103.349 -0.108
201709 -0.119 104.136 -0.152
201712 0.297 104.011 0.380
201803 -0.108 105.290 -0.137
201806 -0.191 106.317 -0.239
201809 -0.157 106.507 -0.196
201812 -0.074 105.998 -0.093
201903 -0.098 107.251 -0.122
201906 -0.180 108.070 -0.222
201909 -0.080 108.329 -0.098
201912 0.046 108.420 0.056
202003 -0.214 108.902 -0.262
202006 -0.191 108.767 -0.234
202009 -0.201 109.815 -0.244
202012 -0.157 109.897 -0.190
202103 -0.008 111.754 -0.010
202106 -0.012 114.631 -0.014
202109 -0.092 115.734 -0.106
202112 -0.033 117.630 -0.037
202203 -0.179 121.301 -0.196
202206 -0.114 125.017 -0.121
202209 -0.016 125.227 -0.017
202212 -0.019 125.222 -0.020
202303 0.027 127.348 0.028
202306 0.022 128.729 0.023
202309 0.054 129.860 0.055
202312 -0.023 129.419 -0.024
202403 -0.064 131.776 -0.065
202406 -0.048 132.554 -0.048
202409 -0.059 133.029 -0.059
202412 0.120 133.157 0.120

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Nephros  (NAS:NEPH) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Nephros Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Nephros's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Nephros Business Description

Traded in Other Exchanges
Address
380 Lackawanna Place, South Orange, NJ, USA, 07079
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.
Executives
Arthur H Amron director C/O WEXFORD CAPITAL LP, 777 WEST PUTNAM AVENUE, FIRST FLOOR, GREENWICH CT 06830
Banks Robert R. Jr. director, officer: President and CEO C/O 380 LACKAWANNA PLACE, SOUTH ORANGE NJ 07079
Judy Krandel officer: Chief Financial Officer 320 W. 37TH STREET, 13TH FLOOR, NEW YORK NY 10018
Joseph Michael Harris director C/O 380 LACKAWANNA PLACE, SOUTH ORANGE NJ 07079
Wesley S. Lobo officer: Chief Marketing Officer C/O 380 LACKAWANNA PLACE, SOUTH ORANGE NJ 07079
Tom Gwydir director C/O 380 LACKAWANNA PLACE, SOUTH ORANGE NJ 07079
Andrew Astor officer: Chief Financial Officer 380 LACKAWANNA PLACE, SOUTH ORANGE NJ 07079
Charles E Davidson director, 10 percent owner C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH FL 33401
Wexford Capital Lp director, 10 percent owner 777 WEST PUTNAM AVENUE, 1ST FLOOR, GREENWICH CT 06830
Joseph Jacobs director, 10 percent owner C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH FL 33401
Wexford Gp Llc director, 10 percent owner C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH CT 33401
Oliver J. Spandow director C/O 380 LACKAWANNA PLACE, SOUTH ORANGE NJ 07079
Daniel S. D'agostino officer: Chief Financial Officer C/O 380 LACKAWANNA PLACE, SOUTH ORANGE NJ 07079
Daron Evans director, officer: President and CEO C/O NEPHROS, INC., 380 LACKAWANNA PLACE, SOUTH ORANGE NJ 07079
Alisa Lask director C/O 380 LACKAWANNA PLACE, SOUTH ORANGE NJ 07079

Nephros Headlines

From GuruFocus

Q3 2023 Nephros Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q2 2022 Nephros Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q3 2021 Nephros Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Nephros Inc Interview with Planet MicroCap Transcript

By GuruFocus Research 02-08-2024

Nephros Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-08-2024

Q4 2022 Nephros Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q3 2024 Nephros Inc Earnings Call Transcript

By GuruFocus News 11-08-2024

Nephros Inc at LD Micro Invitational Conference Transcript

By GuruFocus Research 02-08-2024